• Busca persones
• Intranet

Neurofarmacologia Rafael Maldonado

Publicacions 2024 (2)

• Bergada A. Cognitive and synaptic outcomes of targeting peripheral cannabinoid type-1 receptor: focus on naïve and intellectual disability mouse models. Universitat Pompeu Fabra. Director: Ozaita A, Maldonado R. Fecha lectura: 03/04/2024.
• Grau S, Vela JM, Gurt A, Barceló-Vidal J, Ojeda FA, Lopez I, Gómez-García L, Loza MI, Martín-García E, Maldonado R^*, Monfort J, SIGMA Group. Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients. J. Infect. 2024; 88(2): 187-190.